Security key
42225T107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 40,018,208
- Total 13F value
- $1,463,894,335
- Share change
- +6,034,391
- Put/Call ratio
- 39%
- SEC-reported price per share
- $36.60
- Number of holders
- 138
- Value change
- +$230,365,790
- Number of buys
- 86
- Number of sells
- 57
- Shares outstanding
- 75,234,467
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
138
Top holders
10
HCAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Health Catalyst, Inc. SEC filings
Health Catalyst, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 42225T107
Recent filing periods:
Ownership snapshot
Top reported holders of HCAT - Health Catalyst, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Norwest Venture Partners ...
Disclosed value leader
Norwest Venture Partners ...
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 3.1%
Showing 1-6 of 15 holder rows.
Quick read
Norwest Venture Partners XI, LP leads the comparable SEC ownership view at 3.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Norwest Venture Partners XI, LP's linked filing trail.
Comparable ownership
Top 5
Norwest Venture Partners XI, LP
3.1%
Norwest Venture Partners XII, LP
3.1%
VANGUARD GROUP INC
2.7%
WELLINGTON MANAGEMENT GROUP LLP
2.5%
BlackRock Finance, Inc.
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Norwest Venture Partners XI, LP |
13F
Company
|
3.1%
|
$68,610,000
2,352,091 shares
|
— | 30 Jun 2020 |
| Norwest Venture Partners XII, LP |
13F
Company
|
3.1%
|
$68,610,000
2,352,090 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
2.7%
|
$60,176,000
2,062,909 shares
|
— | 30 Jun 2020 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.5%
|
$54,353,000
1,863,291 shares
|
— | 30 Jun 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
2.4%
|
$53,741,000
1,842,347 shares
|
— | 30 Jun 2020 |
| Capital Research Global Investors |
13F
Company
|
2%
|
$43,644,000
1,496,200 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
138
Shares
40,018,208
Rows available
138
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
127
Q3 2020 holders
138
Holder diff
11
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend